Stai usando un browser molto obsoleto. Puoi incorrere in problemi di visualizzazione di questo e altri siti oltre che in problemi di sicurezza. . Dovresti aggiornarlo oppure usarne uno alternativo, moderno e sicuro.
chi segue AVII? AVI BioPharma announces that the results of its Phase 1 clinical trial assessing the "proof of concept" and safety of AVI-4658 http://finance.yahoo.com/q?s=avii&d=t 1.39 : Co announces that the results and scientific findings of its Phase 1 clinical trial assessing the "proof of concept" and safety of AVI-4658 in patients with Duchenne Muscular Dystrophy (DMD) have been published. These findings, which show that treatment with AVI-4658 was safe and effective in inducing dystrophin expression, suggest that AVI-4658 could have promise as a drug for the treatment of DMD.